Search Result |
Top |
Entry | Name | Formula | Mass |
---|---|---|---|
C01242 |
[Protein]-S8-aminomethyldihydrolipoyllysine [H-protein]-S-aminomethyldihydrolipoyllysine S-Aminomethyldihydrolipoylprotein [Glycine-cleavage complex H protein]-S-aminomethyl-N6-dihydrolipoyl-L-lysine [GCSH]-S-aminomethyl-N6-dihydrolipoyl-L-lysine [GcvH]-S-aminomethyl-N6-dihydrolipoyl-L-lysine |
C9H19N2OS2R | |
C02051 |
Lipoylprotein [H-protein]-lipoyllysine [GCSH]-N6-lipoyl-L-lysine [GcvH]-N6-lipoyl-L-lysine [Glycine cleavage system H]-N6-lipoyl-L-lysine [Glycine-cleavage complex H protein]-N6-lipoyl-L-lysine |
C8H14NOS2R | |
C02972 |
Dihydrolipoylprotein [H-protein]-dihydrolipoyllysine [GCSH]-N6-[(R)-dihydrolipoyl]-L-lysine [GcvH]-N6-[(R)-dihydrolipoyl]-L-lysine [Glycine cleavage system H]-N6-[(R)-dihydrolipoyl]-L-lysine |
C8H16NOS2R | |
C03410 |
N-Glycoloyl-neuraminate N-Glycolylneuraminate Neu5Gc |
C11H19NO10 | 325.1009 |
C03691 |
CMP-N-glycoloylneuraminate CMP-N-glycolylneuraminate CMP-Neu5Gc |
C20H31N4O17P | 630.1422 |
C05955 |
Prostaglandin C2 PGC2 |
C20H30O4 | 334.2144 |
C06297 |
NeuGc-alpha2->8NeuGc2->3Gal-beta1->4Glc-beta1->1'Cer NeuGc-alpha2->8NeuGc2->3LacCer |
C53H90N3O31R | |
C06300 |
NeuGc-alpha2->8NeuGc-alpha2->8NeuGc2->3LacCer NeuGc-alpha2->8NeuGc-alpha2->8NeuGc2->3Gal-beta1->4Glc-beta1->1'Cer |
C64H107N4O40R | |
C06302 |
GalNAc-beta1->4(NeuGc-alpha2->8NeuGc2->3)LacCer GalNAc-beta1->4(NeuGc-alpha2->8NeuGc2->3)Gal-beta1->4Glc-beta1->1'Cer |
C61H103N4O36R | |
C15618 |
Sobetirome GC-1 |
C20H24O4 | 328.1675 |
C21279 |
BGC 945 ONX 0801 |
C32H33N5O10 | 647.2227 |
C22157 |
Glycine cleavage system H [Glycine cleavage system H]-L-lysine [GcvH]-L-lysine [GCSH]-L-lysine |
NH2R | |
C22159 |
[Glycine cleavage system H]-N6-octanoyl-L-lysine [GcvH]-N6-octanoyl-L-lysine [GCSH]-N6-octanoyl-L-lysine |
C8H16NOR |
[ KEGG | DISEASE | DRUG | MEDICUS ] |